A randomised controlled trial of a tele-based lifestyle intervention for colorectal cancer survivors ('CanChange'): study protocol.
BACKGROUND
Colorectal cancer survivors may suffer from a range of ongoing psychosocial and physical problems that negatively impact on quality of life. This paper presents the study protocol for a novel telephone-delivered intervention to improve lifestyle factors and health outcomes for colorectal cancer survivors.


METHODS
Approximately 350 recently diagnosed colorectal cancer survivors will be recruited through the Queensland Cancer Registry and randomised to the intervention or control condition. The intervention focuses on symptom management, lifestyle and psychosocial support to assist participants to make improvements in lifestyle factors (physical activity, healthy diet, weight management, and smoking cessation) and health outcomes. Participants will receive up to 11 telephone-delivered sessions over a 6 month period from a qualified health professional or 'health coach'. Data collection will occur at baseline (Time 1), post-intervention or six months follow-up (Time 2), and at 12 months follow-up for longer term effects (Time 3). Primary outcome measures will include physical activity, cancer-related fatigue and quality of life. A cost-effective analysis of the costs and outcomes for survivors in the intervention and control conditions will be conducted from the perspective of health care costs to the government.


CONCLUSIONS
The study will provide valuable information about an innovative intervention to improve lifestyle factors and health outcomes for colorectal cancer survivors.


BACKGROUND
ACTRN12608000399392.
Hawkes
Anna L
AL
Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Australia. annahawkes@cancerqld.org.au
Pakenham
Kenneth I
KI
Courneya
Kerry S
KS
Gollschewski
Sara
S
Baade
Peter
P
Gordon
Louisa G
LG
Lynch
Brigid M
BM
Aitken
Joanne F
JF
Chambers
Suzanne K
SK
D002985:Clinical Protocols; D015179:Colorectal Neoplasms / Q000523:psychology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008019:Life Style; D008297:Male; D011446:Prospective Studies; D012107:Research Design; D017741:Survivors / Q000523:psychology*
Support Care Cancer. 2008 Oct;16(10):1097-104
18347819
J Clin Oncol. 2006 Nov 10;24(32):5125-31
17093274
Psychooncology. 2009 Feb;18(2):216-20
18618899
Lancet. 2001 Apr 14;357(9263):1191-4
11323066
J Consult Clin Psychol. 2007 Apr;75(2):336-43
17469891
Psychooncology. 2009 Apr;18(4):449-55
19241477
CA Cancer J Clin. 2006 Nov-Dec;56(6):323-53
17135691
Ann Behav Med. 2007 Oct;34(2):135-43
17927552
CA Cancer J Clin. 2003 Sep-Oct;53(5):268-91
14570227
Ann Behav Med. 2009 Feb;37(1):58-69
19252962
Psychooncology. 2009 Apr;18(4):337-42
19306338
Psychooncology. 2001 Jan-Feb;10(1):19-28
11180574
Cancer. 2000 Mar 15;88(6):1294-303
10717609
BMC Public Health. 2009 Nov 23;9:427
19930615
J Trauma Stress. 1996 Jul;9(3):455-71
8827649
Can J Appl Sport Sci. 1985 Sep;10(3):141-6
4053261
Ann Behav Med. 2002 Winter;24(1):49-58
12008794
J Psychosom Res. 2005 Jan;58(1):29-33
15771867
J Clin Oncol. 2008 May 1;26(13):2198-204
18445845
J Nutr. 2007 Jan;137(1 Suppl):243S-248S
17182834
Bone Marrow Transplant. 1996 May;17(5):843-7
8733707
Hematol Oncol Clin North Am. 2008 Apr;22(2):319-42, viii
18395153
Cancer Detect Prev. 2005;29(1):25-36
15734214
Psychooncology. 2006 Sep;15(9):749-58
16304622
Psychooncology. 2005 Nov;14(11):949-61
15669014
J Clin Oncol. 2005 Aug 20;23(24):5814-30
16043830
Behav Ther. 2016 Nov;47(6):869-885
27993338
J Consult Clin Psychol. 1996 Dec;64(6):1152-68
8991302
Epilepsia. 2006 Dec;47(12):2173-9
17201719
Behav Res Ther. 2006 Jan;44(1):1-25
16300724
Med Care. 1992 Jun;30(6):473-83
1593914
Psychooncology. 2006 Jan;15(1):20-30
15929055
Behav Res Ther. 2007 Oct;45(10):2372-86
17544361
J Clin Oncol. 1993 Mar;11(3):570-9
8445433
Cancer. 2002 Mar 15;94(6):1854-66
11920549
Int J Obes Relat Metab Disord. 2003 Aug;27(8):955-62
12861237
Eur J Cancer Care (Engl). 2003 Dec;12(4):347-57
14982314